PAFAH1B3 Antibodies

Santa Cruz Biotechnology delivers a wide array of PAFAH1B3 monoclonal antibodies for research focused on understanding platelet-activating factor acetylhydrolase 1b, catalytic subunit 3. PAFAH1B3 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PAFAH1B3 plays a crucial role in lipid metabolism and inflammatory responses by hydrolyzing platelet-activating factor (PAF). PAFAH1B3 is significant in various physiological processes, including cell signaling and immune response regulation. Research has shown PAFAH1B3's involvement in multiple cellular pathways and its potential implications in disease mechanisms. Understanding PAFAH1B3 function is essential for elucidating its involvement in diseases such as cardiovascular disorders and neurodegenerative conditions. Investigating PAFAH1B3 expression patterns can provide valuable information about disease progression and potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of PAFAH1B3's role in health and disease.